Li-ping Liu

Shenzhen, 518020, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Correction: Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.

Correction: Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.

Journal: PloS one

Published: September 05, 2025

Novel serum small extracellular vesicle miRNAs with multi-target RCA-CRISPR sensor for liver cancer detection.

Novel serum small extracellular vesicle miRNAs with multi-target RCA-CRISPR sensor for liver cancer detection.

Journal: Journal of translational medicine

Published: April 03, 2025

Long Non-coding RNA PCED1B Antisense RNA 1 Promotes Cell Proliferation and Invasion in Hepatocellular Carcinoma by Regulating the MicroRNA-34a/CD44 Axis.

Long Non-coding RNA PCED1B Antisense RNA 1 Promotes Cell Proliferation and Invasion in Hepatocellular Carcinoma by Regulating the MicroRNA-34a/CD44 Axis.

Journal: Current medical science

Published: May 30, 2022

ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway.

ZBP-89 negatively regulates self-renewal of liver cancer stem cells via suppression of Notch1 signaling pathway.

Journal: Cancer letters

Published: September 06, 2019

Research on circadian clock genes in common abdominal malignant tumors.

Research on circadian clock genes in common abdominal malignant tumors.

Journal: Chronobiology international

Published: April 25, 2019

Targeting ZBP-89 for the treatment of hepatocellular carcinoma.

Targeting ZBP-89 for the treatment of hepatocellular carcinoma.

Journal: Expert opinion on therapeutic targets

Published: August 26, 2018

Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.

Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies.

Journal: Therapeutic advances in medical oncology

Published: July 26, 2018

UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.

UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.

Journal: Biochemical and biophysical research communications

Published: June 09, 2018

CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma.

CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma.

Journal: Oncology reports

Published: January 19, 2018

Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma.

Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma.

Journal: Translational oncology

Published: December 13, 2017

UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.

UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.

Journal: Biochemical and biophysical research communications

Published: August 18, 2017

miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.

miR-107-mediated decrease of HMGCS2 indicates poor outcomes and promotes cell migration in hepatocellular carcinoma.

Journal: The international journal of biochemistry & cell biology

Published: July 13, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026